Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Mini-Tabs Plus Ribavirin for Children Aged 3 –11 Years with Hepatitis C Genotype 1a
ConclusionThe mini-tablet combination of OBV, PTV, ritonavir, and DSV plus ribavirin to treat HCV GT1a infection for 12 weeks was highly effective and suitable in children 3–11 years of age.Trial RegistrationClinicalTrials.gov identifier, NCT02486406.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Children | Drugs & Pharmacology | Headache | Hepatitis | Hepatitis C | Migraine | Norvir | Pediatrics | Study